Maine Fires the First Price Control Salvo
Executive Summary
Although there's been plenty of noise coming out capitol Hill regarding the issues of prescription drug prices and expanding Medicare to cover such drugs, sharp debate on the merits of over a dozen pieces of proposed legislation--as well as election year politics--have stalled congressional action. But the states are beginning to make their own moves on the price control front, with Maine enacting the first price control (well, almost) legislation. However the new Maine law, as well as any similar laws passed by other states will likely face tough legal challenges.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.